Clearmind Medicine Inc. (CMND)

Nasdaq Pharmaceutical Pharmaceutical Preparations SIC: 2834
D
Pipeline Grade

Drug Pipeline (0 Assets)

No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.

Upcoming Catalysts

DateEventDrug
2026-12-31 Phase2 Readout

Active Clinical Trials (1)

NCT #TitlePhaseStatusEnrollment
NCT05913752 A First in Human Study of CMND-100 in Healthy and Alcohol Use Disorder (AUD) Subjects PHASE2 Recruiting 84

Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.

More Analysis